CorMedix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	311.71	43.47	-	0.07	0.19
Revenue Growth (YoY)	617.03%	-	-	-65.74%	-20.19%
Cost of Revenue	-22.09	-3.03	-	0	0.15
Gross Profit	275.75	40.28	-	0.06	0.04
Selling, General & Admin	-106.27	-58.7	35.8	20.01	16.35
Research & Development	-19.33	-3.94	13.16	10.68	13.13
Total Operating Expenses	-125.61	-62.64	48.96	30.69	29.48
Operating Income	150.14	-22.36	-48.96	-30.62	-29.44
Interest Income	3.85	2.58	2.68	0.33	0.01
Interest Expense	-2.78	-0.04	-0.03	-0.03	-0.02
Other Non-Operating Income (Expense)	-1.19	0.49	-0.03	0.04	-0.02
Total Non-Operating Income (Expense)	-0.13	3.03	2.62	0.34	-0.02
Pretax Income	150.02	-19.33	-46.34	-30.29	-29.46
Provision for Income Taxes	13.04	1.4	-	-0.59	-1.25
Net Income	163.06	-17.93	-46.34	-29.7	-28.21
Net Income to Common	163.06	-17.93	-46.34	-29.7	-28.21
Shares Outstanding (Basic)	72	59	51	40	38
Shares Outstanding (Diluted)	80	59	51	40	38
Shares Change (YoY)	36.41%	15.65%	26.39%	6.93%	31.87%
EPS (Basic)	2.25	-0.30	-0.91	-0.74	-0.75
EPS (Diluted)	2.04	-0.30	-0.91	-0.74	-0.75
Free Cash Flow	172.79	-50.73	-38.74	-24.58	-22.58
Free Cash Flow Per Share	2.15	-0.86	-0.76	-0.61	-0.60
Gross Margin	88.46%	92.66%	-	94.29%	22.00%
Operating Margin	48.17%	-51.43%	-	-46819.91%	-15417.51%
Profit Margin	52.31%	-41.24%	-	-45409.90%	-14774.70%
FCF Margin	55.43%	-116.70%	-	-37573.53%	-11826.24%
EBITDA	165.53	-21.9	-48.75	-30.41	-29.26
EBITDA Margin	53.10%	-50.37%	-	-46500.32%	-15324.80%
EBIT	150.14	-22.36	-48.96	-30.62	-29.44
EBIT Margin	48.17%	-51.43%	-	-46819.91%	-15417.51%
Effective Tax Rate	8.69%	-7.22%	0.00%	1.93%	4.24%

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q